MedX Health Corp.
3535 Laird Road, Unit 2
Tel: 905-826-0766 or 888-363-3112
53 articles with MedX Health Corp.
MedX Health Corp. will be presenting at this year's virtual Fall Investor Summit on Tuesday, November 17th at 4:00PM (EST) / 1:00PM (PST),
MedX enters into a sales agency agreement with specialty medical device distribution group Ziemer Professional Corp., targeting sales efforts within the medical, athletic, and pain management clinic markets
MedX Health Corp., a Company focused on becoming the global leader in teledermatology, announces that it has appointed Anthony Milonas and Wayne Cockburn as Directors of the Company, effective immediately.
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the three and six-months ended June 30, 2020, which are also available on SEDAR ( www.sedar.com ). The Company reported revenue of $69,452 for the three months ended June 30, 2020, compared with revenue of $259,108 for the three months ended June 30, 2019. Revenue from SIAscopy™ of $31,029 for the second quarter was higher than
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced that it has completed management changes to enhance its focus on its dermatological services and products (“DSP”) including DermSecure™ and SIAscopy™. Mike Druhan, who has championed SIAscopy™ within the Company for a number of years, has been appointed President, Dermatological Services and Products. The supporting teams in sales, training, pro
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the three-months ended March 31, 2020, which are also available on SEDAR (www.sedar.com).
MedX Health Corp. (“MedX”) ( MDX – TSXV), announced today that President and CEO Scott Spearn has resigned for family reasons, effective immediately. Rob von der Porten, Chairman of the Board, has been named interim Executive Chair. Mr. Spearn will also be retiring from the Board at or prior to the next AGM. The Board will commence a search for suitable candidates to take on the CEO position. “The Board than
MedX Health Corp. announces that it has signed an Exclusive Distribution Agreement with EMC LABS, S.A.P.I. DE C.V., operating as MedX Mexico, which plans to launch an aggressive ease-of-access skin scanning/assessment program throughout Mexico, using MedX’s SIAscopy on DermSecure™ Telemedicine platform.
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the year ended December 31, 2019, which are also available on SEDAR ( www.sedar.com ). The Company reported revenue of $860,248 for the year ended December 31, 2019, compared with revenue of $1,087,426 for the year ended December 31, 2018. Sales were lower in 2019 from both its SIAscopy skin assessment technology and therapeutic
MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that pursuant to the agreement for an online marketing and awareness program through AGORACOM, that was announced in the Press Release dated June 1, 2020, it has settled the first payment to AGORACOM, in the amount of 12,000 plus HST, or $13,560, by issuance on June 1, 2020, of 90,400 shares at an issue price of $0.15 per share.
MedX Health Corp. is pleased to announce that it is implementing an online marketing and awareness program through AGORACOM.
MedX Health Corp. Appoints Nick Hoffman, Medical Imaging and Equipment Executive, as Director Business Development
MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of medical equipment industry executive Nick Hoffman as Director, Business Development, effective immediately.
MedX Health Corp. Appoints Veteran Healthcare Industry Executive Damon Goodwin as Global Director of Sales
MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of healthcare industry executive Damon Goodwin as Global Director of Sales, effective immediately. Mr. Goodwin will play an integral part in MedX’s revenue growth by building global partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in Mexico, Brazil and the USA, he will also b
MedX Health Corp. Announces Closing of Initial Tranches of Non-Brokered Private Placement and Announces That Due to COVID-19 Delays It Will Postpone the Release of Its Annual Financial Statements and Related Disclosures
MedX Health Corp. is pleased to announce that further to the Conditional Approval from the TSX Venture Exchange for a non-brokered Private Placement to accredited investors of up to 25,000,000 units at $0.12 per unit, to raise up to $3,000,000 that was announced on March 6, 2020, the closing of two tranches of that placement have taken place, the first on April 22, and the second on April 27, 2020, for a total of 9,908,006 units, raising a total of $1,188,960.
MedX Receives MDSAP Certification, The Highest Regulatory Standard in the Medical Device Manufacturing Industry
MedX Health Corp. (“MedX”) (TSX-V: MDX) a leading medical device and software company focused on skin assessment in identifying suspicious moles and lesions by utilizing its SIAscopy optical scanning technology coupled with its SIAscopy on DermSecure™ telemedicine platform, is pleased to announce that it has achieved a recommendation for continued certification on successful completion of an audit under the Medica
MedX Health Corp., announces that it has entered into an agreement to settle $372,071 of debt owed to an arm’s length trade creditor, subject to all relevant consents and approvals.
MedX Health Corp., dedicated to the early detection of skin cancer, announces that a total of 5,990,000 stock options have been granted to directors, Officers and employees and consultants.
The Company reported revenue of $234,977 for the three months ended September 30, 2019, compared with revenue of $180,404 for the three months ended September 30, 2018.
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) experienced strong interest for its SIAscopy on DermSecureTM platform from physicians and dermatologists in Brazil during the recent 74th Congress of the Brazilian Society of Dermatology held in Rio de Janeiro in September 2019
The Company reported revenue of $259,108 for the three months ended June 30, 2019, compared with revenue of $405,707 for the three months ended June 30, 2018.